Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
XIAOMI-W
01810
5
TENCENT
00700
No Data
12 Health Care Stocks Moving In Wednesday's After-Market Session
PharmaCyte Biotech Monetizes Femasys Stake; Cash And Securities Expected At ~$20M After Monetization, Up From $13.3M
Express News | PharmaCyte Biotech Successfully Monetizes Femasys Stake, Strengthening Cash Position and Underscoring Strategic Capital Deployment
Laidlaw Initiates Femasys(FEMY.US) With Buy Rating, Announces Target Price $6.5
Laidlaw & Co. Initiates Coverage On Femasys With Buy Rating, Announces Price Target of $6.5
Femasys Analyst Ratings